The OncoScan somatic mutation panel was then used to analyze 64 specific mutations in nine cancer‐related genes (BRAF, KRAS, EGFR, IDH1, IDH2, PTEN, PIK3CA, NRAS, and TP53). Here, IDH2 is linked to cancer.